Quetiapine
Product Images NDC 10135-656
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 10135-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse (study 3) (Quetiapine Extended Release 02)
Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 9) (Quetiapine Extended Release 03)
Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 10) (Quetiapine Extended Release 04)
Principal Display Panelndc 10135-0656-60quetiapine Extended-release Tablets, Usp150 mg Once Daily60 Tabletsrx Only (Quetiapine Extended Release 05)
NDC 10135-0656-60 is a medication manufactured and distributed by Marlex Pharmaceuticals. Each tablet contains 172.7 mg of quetiapine fumarate, equivalent to 150 mg of quetiapine. The medication should be swallowed whole and not split, crushed, or chewed. The usual dosage is once daily, as indicated by the prescribing information. Quetiapine should be stored at 25°C (77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The medication should be kept out of the reach of children.*
Principal Display Panelndc 10135-0657-60quetiapine Extended-release Tablets, Usp200 mg Once Daily60 Tabletsrx Only (Quetiapine Extended Release 06)
This is a description of a medication called Quetiapine, with the National Drug Code 10135-0657-60, manufactured and distributed by Marlex Pharmaceuticals. Each tablet contains 230.26mg of Quetiapine Fumarate equivalent to 200mg of Quetiapine. The tablets must be swallowed whole, and not crushed or chewed. The recommended dosage is once daily, and users should consult the accompanying prescribing information before use. The medication should be stored at 25°C (77°F) with excursions of 15° to 30°C (59°F to 86°F) allowed. The medication must be kept out of the reach of children. The package contains 60 tablets.*
Principal Display Panelndc 10135-0658-60quetiapine Extended-release Tablets, Usp300 mg Once Daily60 Tabletsrx Only (Quetiapine Extended Release 07)
This is a description of a medication with the National Drug Code (NDC) 10135-0658-60. Each tablet contains 345.38 mg of quetiapine fumarate, which is equivalent to 300 mg of quetiapine. The medication should be swallowed whole and should not be split, crushed, or chewed. The usual dosage is once daily, and the medication should be stored at room temperature. The medication is manufactured and distributed by Marlex Pharmaceuticals, Inc. This information is included with the prescribing information.*
Principal Display Panelndc 10135-0659-60quetiapine Extended-release Tablets, Usp400 mg Once Daily60 Tabletsrx Only (Quetiapine Extended Release 08)
This is a medication description for Quetiapine, also known as NDC 10135-0659-60. Each tablet contains 460.5 mg of quetiapine fumarate equivalent to 400 mg of quetiapine. The medication is meant to be swallowed whole and not split, crushed, or chewed. The recommended dosage is once daily, and specific prescribing information should be consulted. The medication should be stored at room temperature, between 15-30°C. This medication is distributed by Marlex Pharmaceuticals and comes in a bottle with 60 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.